In patients with active IBD, pro-inflammatory cytokines such as TNF-α, IL-1β, IL-6, IL-12, and IL-23 are significantly elevated, while anti-inflammatory cytokines such as IL-10 and IL-4 are expressed at insufficient levels [59, 60]. Here, IL1B is linked to inflammatory bowel disease.